Skip to main content

Harnsteine

Metabolismus und Diagnostik

Der Urologe volume 45, pages 181–184 (2006)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Abb. 1

Literatur

  1. Abate N, Chandalia M, Cabo-Chan AV Jr et al. (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65: 386–392

    Article  PubMed  Google Scholar 

  2. Bellin MF, Renard-Penna R, Conort P et al. (2004) Helical CT evaluation of the chemical composition of urinary tract calculi with a discriminant analysis of CT-attenuation values and density. Eur Radiol 14: 2134–2140

    Article  PubMed  Google Scholar 

  3. Berg W, Schanz H, Eisenwinter B, Schorch P (1992) The incidence distribution and development of a trend of urinary stone substances. An evaluation of the data on over 210,000 urinary stone analyses from the area of the former DDR. Urologe A 31: 98–102

    PubMed  Google Scholar 

  4. Bichler KH (2006) Thirty-eight years of stone meetings in Europe. Urol Res 34: 70–78

    Article  PubMed  Google Scholar 

  5. Borghi L, Schianchi T, Meschi T et al. (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346: 77–84

    Article  PubMed  Google Scholar 

  6. Botzenhart E, Vester U, Schmidt C et al. (2002) Cystinuria in children: distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes. Kidney Int 62: 1136–1142

    Article  PubMed  Google Scholar 

  7. Brandle E, Hautmann R, Alken P et al. (1997) Diagnosis of urinary calculi. Urologe A 36: 579–581

    PubMed  Google Scholar 

  8. Demirel A, Suma S (2003) The efficacy of non-contrast helical computed tomography in the prediction of urinary stone composition in vivo. J Int Med Res 31: 1–5

    PubMed  Google Scholar 

  9. Deveci S, Coskun M, Tekin MI et al. (2004) Spiral computed tomography: role in determination of chemical compositions of pure and mixed urinary stones – an in vitro study. Urology 64: 237–240

    Article  PubMed  Google Scholar 

  10. Hesse A (2002) Urinary calculi. 1: Epidemiology, laboratory diagnosis, genetics and infections. Urologe A 41: 496–506

    Article  PubMed  Google Scholar 

  11. Hesse A, Brandle E, Wilbert D et al. (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44: 709–713

    Article  PubMed  Google Scholar 

  12. Hesse A, Kruse R, Geilenkeuser WJ, Schmidt M (2005) Quality control in urinary stone analysis: results of 44 ring trials (1980–2001). Clin Chem Lab Med 43: 298–303

    Article  PubMed  Google Scholar 

  13. Laube N, Hergarten S, Hoppe B et al. (2004) Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas. J Urol 172: 355–359

    Article  PubMed  Google Scholar 

  14. Laube N, Pullmann M (2006) The use of risk indices: do they predict recurrence? Yes, they (at least some) do. Urol Res 34: 118–121

    Article  PubMed  Google Scholar 

  15. Laube N, Schneider A, Hesse A (2000) A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine. Urol Res 28: 274–280

    Article  PubMed  Google Scholar 

  16. Leusmann DB, Blaschke R, Schmandt W (1990) Results of 5,035 stone analyses: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol 24: 205–210

    PubMed  Google Scholar 

  17. Maalouf NM, Sakhaee K, Parks JH et al. (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65: 1422–1425

    Article  PubMed  Google Scholar 

  18. Moe OW, Abate N, Sakhaee K (2002) Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 31: 895–914

    Article  PubMed  Google Scholar 

  19. Motley G, Dalrymple N, Keesling C et al. (2001) Hounsfield unit density in the determination of urinary stone composition. Urology 58: 170–173

    Article  PubMed  Google Scholar 

  20. Nakada SY, Hoff DG, Attai S et al. (2000) Determination of stone composition by noncontrast spiral computed tomography in the clinical setting. Urology 55: 816–819

    Article  PubMed  Google Scholar 

  21. Pak CY, Asplin JR, Ogawa Y et al. (2003) Evaluation of stone-forming patients, chap. 3. In: Segura JW, Conort P, Khoury S, Pak CY, Preminger GM, Tolley D (eds) Stone disease, 1. edn. Health Publications, Paris, pp 123–132

  22. Ramey SL, Franke WD, Shelley MC (2004) Relationship among risk factors for nephrolithiasis, cardiovascular disease, and ethnicity: focus on a law enforcement cohort. AAOHN J 52: 116–121

    PubMed  Google Scholar 

  23. Schmidt C, Albers A, Tomiuk J et al. (2002) Analysis of the genes SLC7A9 and SLC3A1 in unclassified cystinurics: mutation detection rates and association between variants in SLC7A9 and the disease. Clin Nephrol 57: 342–348

    PubMed  Google Scholar 

  24. Schmidt C, Tomiuk J, Botzenhart E et al. (2003) Genetic variations of the SLC7A9 gene: allele distribution of 13 polymorphic sites in German cystinuria patients and controls. Clin Nephrol 59: 353–359

    PubMed  Google Scholar 

  25. Schmidt C, Vester U, Hesse A et al. (2004) The population-specific distribution and frequencies of genomic variants in the SLC3A1 and SLC7A9 genes and their application in molecular genetic testing of cystinuria. Urol Res 32: 75–78

    Article  PubMed  Google Scholar 

  26. Schmidt C, Vester U, Wagner CA et al. (2003) Significant contribution of genomic rearrangements in SLC3A1 and SLC7A9 to the etiology of cystinuria. Kidney Int 64: 1564–1572

    Article  PubMed  Google Scholar 

  27. Schubert G (2006) Stone analysis. Urol Res 34: 146–150

    Article  PubMed  Google Scholar 

  28. Siener R, Glatz S, Nicolay C, Hesse A (2004) The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12: 106–113

    PubMed  Google Scholar 

  29. Straub M, Hautmann RE (2004) Prevention of nephrolithiasis. Established strategies and new concepts. Urologe A 43: 440–449

    Article  PubMed  Google Scholar 

  30. Straub M, Strohmaier WL, Berg W et al. (2005) Diagnosis and metaphylaxis of stone disease Consensus concept of the National Working Committee on Stone Disease for the Upcoming German Urolithiasis Guideline. World J Urol 23: 309–323

    Article  PubMed  Google Scholar 

  31. Strazzullo P, Barba G, Vuotto P et al. (2001) Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant 16: 2232–2235

    Article  PubMed  Google Scholar 

  32. Strazzullo P, Cappuccio FP (1995) Hypertension and kidney stones: hypotheses and implications. Semin Nephrol 15: 519–525

    PubMed  Google Scholar 

  33. Strohmaier WL (2000) Course of calcium stone disease without treatment. What can we expect? Eur Urol 37: 339–344

    Article  PubMed  Google Scholar 

  34. Sutton RA (2006) The use of risk indices: do they predict recurrence? Urol Res 34: 122–125

    Article  PubMed  Google Scholar 

  35. Tiselius HG (1991) Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 47: 255–259

    PubMed  Google Scholar 

  36. Tiselius HG (1997) Risk formulas in calcium oxalate urolithiasis. World J Urol 15: 176–185

    Article  PubMed  Google Scholar 

  37. Trinchieri A, Curhan GC, Karlsen S, Jun Wu K (2003) Epidemiology, chap. 1. In: Segura JW, Conort P, Khoury S, Pak CY, Preminger GM, Tolley D (eds) Stone disease, 1. edn. Health Publications, Paris, pp 13–30

  38. Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 134: 1242–1244

    PubMed  Google Scholar 

  39. Zarse CA, McAteer JA, Tann M et al. (2004) Helical computed tomography accurately reports urinary stone composition using attenuation values: in vitro verification using high-resolution micro-computed tomography calibrated to fourier transform infrared microspectroscopy. Urology 63: 828–833

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Affiliations

  1. Arbeitsgruppe Harnsteine, Abteilung Urologie und Kinderurologie, Universitätsklinikum, Prittwitzstraße 43, 89075, Ulm, Deutschland

    R. E. Hautmann &  M. Straub

Authors
  1. R. E. Hautmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Straub
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Straub.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hautmann, R.E., Straub, M. Harnsteine. Urologe 45, 181–184 (2006). https://doi.org/10.1007/s00120-006-1184-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-006-1184-6